Pacira BioSciences, Inc. PCRX Cash ratio
Cash ratio at other companies
Other financials
Where this comes from
Calculated from Pacira BioSciences, Inc.’s reported figures.
Based on the most recent quarter.
The official record: Pacira BioSciences, Inc.’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Pacira BioSciences, Inc.'s cash ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Pacira BioSciences, Inc.'s cash ratio?
- Pacira BioSciences, Inc. (PCRX) reported cash ratio of 1.3× in Q1 2026.
- How has Pacira BioSciences, Inc.'s cash ratio changed year-over-year?
- Pacira BioSciences, Inc.'s cash ratio increased by 47.2% year-over-year, from 0.9× to 1.3×.
- What is the long-term trend for Pacira BioSciences, Inc.'s cash ratio?
- Over 5 years (2020 to 2025), Pacira BioSciences, Inc.'s cash ratio has grown at a 27.2% compound annual growth rate (CAGR), from 0.4× to 1.3×.
- What does cash ratio mean?
- Cash and equivalents divided by current liabilities at the quarter end. The most conservative liquidity measure — what the company could pay immediately with cash on hand.